Cargando…

Metastatic Soft Tissue Sarcomas in Adolescents and Young Adults: A Specialist Center Experience

Purpose: Soft tissue sarcomas (STS) account for 8% of all cancers in adolescents and young adults (AYAs). Metastatic STS contribute significantly to disease-related mortality in this age group; however, data are limited due to under-representation in clinical trials. Methods: AYAs aged 18–39 years,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Younger, Eugenie, Husson, Olga, Asare, Bernice, Benson, Charlotte, Judson, Ian, Miah, Aisha, Zaidi, Shane, Dunlop, Alison, Al-Muderis, Omar, van Houdt, Winan J., Jones, Robin L., van der Graaf, Winette T.A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mary Ann Liebert, Inc., publishers 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7757586/ https://www.ncbi.nlm.nih.gov/pubmed/32379517 http://dx.doi.org/10.1089/jayao.2020.0010

Ejemplares similares

Desmoid is not a sarcoma; reply to Sachdev et al.
por: van der Graaf, Winette T.A., et al.
Publicado: (2023)

Desmoid fibromatosis through the patients’ eyes: time to change the focus and organisation of care?
por: Husson, Olga, et al.
Publicado: (2018)

Poor treatment outcomes with palliative gemcitabine and docetaxel chemotherapy in advanced and metastatic synovial sarcoma
por: Pender, Alexandra, et al.
Publicado: (2018)

Health-related quality Of Life In patients with advanced Soft TIssue sarcomas treated with Chemotherapy (The HOLISTIC study): protocol for an international observational cohort study
por: Younger, Eugenie, et al.
Publicado: (2020)

Age-related sarcoma patient experience: results from a national survey in England
por: Younger, Eugenie, et al.
Publicado: (2018)

Liquid Biopsies in Sarcoma Clinical Practice: Where Do We Stand?
por: van der Laan, Pia, et al.
Publicado: (2021)

Pazopanib, a promising option for the treatment of aggressive fibromatosis
por: Szucs, Zoltan, et al.
Publicado: (2017)

The Evaluation of Health-Related Quality of Life Issues Experienced by Patients with Desmoid-Type Fibromatosis (The QUALIFIED Study)—A Protocol for an International Cohort Study
por: Schut, Anne-Rose W., et al.
Publicado: (2021)

Clinical Activity and Tolerability of a 14-Day Infusional Ifosfamide Schedule in Soft-Tissue Sarcoma
por: Martin-Liberal, Juan, et al.
Publicado: (2013)

Unraveling the Heterogeneity of Sarcoma Survivors’ Health-Related Quality of Life Regarding Primary Sarcoma Location: Results from the SURVSARC Study
por: van Eck, Ilse, et al.
Publicado: (2020)

Development of a Disease-Specific Health-Related Quality of Life Questionnaire (DTF-QoL) for Patients with Desmoid-Type Fibromatosis
por: Schut, Anne-Rose W., et al.
Publicado: (2022)

Unraveling Desmoid-Type Fibromatosis-Specific Health-Related Quality of Life: Who Is at Risk for Poor Outcomes
por: Schut, Anne-Rose W., et al.
Publicado: (2022)

Health-Related Quality of Life and Experiences of Sarcoma Patients during the COVID-19 Pandemic
por: Younger, Eugenie, et al.
Publicado: (2020)

Priorities and preferences of advanced soft tissue sarcoma patients starting palliative chemotherapy: baseline results from the HOLISTIC study
por: Younger, E., et al.
Publicado: (2021)

Clinical management and outcomes of primary ovarian leiomyosarcoma – Experience from a sarcoma specialist unit
por: Cojocaru, Elena, et al.
Publicado: (2021)

Unravelling the heterogeneity of soft tissue and bone sarcoma patients’ health-related quality of life: a systematic literature review with focus on tumour location
por: den Hollander, Dide, et al.
Publicado: (2020)

Diagnosed with a Rare Cancer: Experiences of Adult Sarcoma Survivors with the Healthcare System—Results from the SURVSARC Study
por: Drabbe, Cas, et al.
Publicado: (2021)

Quality of life and experiences of sarcoma trajectories (the QUEST study): protocol for an international observational cohort study on diagnostic pathways of sarcoma patients
por: Soomers, Vicky, et al.
Publicado: (2020)

Incorporating the Patient Voice in Sarcoma Research: How Can We Assess Health-Related Quality of Life in This Heterogeneous Group of Patients? A Study Protocol
por: den Hollander, Dide, et al.
Publicado: (2020)

Clinical Impact of Prospective Whole Genome Sequencing in Sarcoma Patients
por: Schipper, Luuk J., et al.
Publicado: (2022)

First line palliative chemotherapy in elderly patients with advanced soft tissue sarcoma
por: Yousaf, Nadia, et al.
Publicado: (2015)

Telemedicine During the COVID-19 Pandemic: Impact on Care for Rare Cancers
por: Smrke, Alannah, et al.
Publicado: (2020)

Prognostic Significance of Bone Metastasis in Soft Tissue Sarcoma Patients Receiving Palliative Systemic Therapy: An Explorative, Retrospective Pooled Analysis of the EORTC-Soft Tissue and Bone Sarcoma Group (STBSG) Database
por: Kantidakis, Georgios, et al.
Publicado: (2022)

The sarcoma diagnostic interval: a systematic review on length, contributing factors and patient outcomes
por: Soomers, Vicky, et al.
Publicado: (2020)

Clinical Characteristics and efficacy of chemotherapy in sclerosing epithelioid fibrosarcoma
por: Chew, Winston, et al.
Publicado: (2018)

Management of Soft Tissue Sarcomas in Extremities: Variation in Treatment Recommendations and Surveillance According to Specialty and Continent
por: Acem, Ibtissam, et al.
Publicado: (2021)

Uterine sarcoma – current perspectives
por: Benson, Charlotte, et al.
Publicado: (2017)

The Perceived Impact of Length of the Diagnostic Pathway Is Associated with Health-Related Quality of Life of Sarcoma Survivors: Results from the Dutch Nationwide SURVSARC Study
por: Soomers, Vicky L. M. N., et al.
Publicado: (2020)

Assessing the Desmoid-Type Fibromatosis Patients' Voice: Comparison of Health-Related Quality of Life Experiences from Patients of Two Countries
por: Timbergen, Milea J. M., et al.
Publicado: (2020)

Clinical Benefit of Second-Line Palliative Chemotherapy in Advanced Soft-Tissue Sarcoma
por: Minchom, Anna, et al.
Publicado: (2010)

Advanced soft-tissue sarcoma and treatment options: critical appraisal of trabectedin
por: Desar, Ingrid M E, et al.
Publicado: (2016)

The route to diagnosis of sarcoma patients: Results from an interview study in the Netherlands and the United Kingdom
por: Soomers, Vicky L. M. N., et al.
Publicado: (2020)

Neoadjuvant Systemic Treatment of Primary Angiosarcoma
por: Heinhuis, Kimberley M., et al.
Publicado: (2020)

New Systemic Therapy Options for Advanced Sarcomas
por: van der Graaf, Winette T. A., et al.
Publicado: (2012)

Adherence to Guidelines for Adult (Non-GIST) Soft Tissue Sarcoma in the Netherlands: A Plea for Dedicated Sarcoma Centers
por: Hoekstra, Harald J., et al.
Publicado: (2017)

Health-Related Quality of Life Issues Experienced by Thoracic and Breast Sarcoma Patients: A Rare and Understudied Group
por: van Eck, Ilse, et al.
Publicado: (2021)

Prognostic factors for soft tissue sarcoma patients with lung metastases only who are receiving first‐line chemotherapy: An exploratory, retrospective analysis of the European Organization for Research and Treatment of Cancer‐Soft Tissue and Bone Sarcoma Group (EORTC‐STBSG)
por: Lindner, Lars H., et al.
Publicado: (2018)

Should Soft Tissue Sarcomas be Treated at a Specialist Centre?
por: Bhangu, A. A., et al.
Publicado: (2004)

Survival and Cost-Effectiveness of Trabectedin Compared to Ifosfamide Monotherapy in Advanced Soft Tissue Sarcoma Patients
por: Verboom, Michiel C., et al.
Publicado: (2019)

Adjuvant Chemotherapy of Soft Tissue Sarcoma—Current Status
por: Judson, Ian
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_8jvu3hk4dkvqbbmbhjl54lrrd6